Pms36 - Switch Patterns and Total Healthcare Costs in Biologic-Naive Patients Initiating Apremilast or a Biologic for the Treatment of Psoriatic Arthritis: Results From a Us Claims Analysis
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1750
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV